L-259-2017
Agreement ID
L-259-2017
Lead IC
NCI
Exclusivity
Nonexclusive
External Party
CRISPR Therapeutics AG
Fiscal Year
2017
Territory
Other
Execution Date
Effective Date
Export Date
Technologies